Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

The relief of leukocytopenia within 1 month after switching risperidone to amisulpride.

Hou YC, Lai CH.

J Neuropsychiatry Clin Neurosci. 2014 Summer;26(3):E40-1. doi: 10.1176/appi.neuropsych.13070162. No abstract available.

PMID:
25093784
2.

Amisulpride versus risperidone in the treatment of depression in patients with schizophrenia: a randomized, open-label, controlled trial.

Kim SW, Shin IS, Kim JM, Lee SH, Lee JH, Yoon BH, Yang SJ, Hwang MY, Yoon JS.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Oct 1;31(7):1504-9. Epub 2007 Jul 13.

PMID:
17692448
3.

Safety profile of amisulpride in short- and long-term use.

Rein W, Coulouvrat C, Dondey-Nouvel L.

Acta Psychiatr Scand Suppl. 2000;400:23-7. Review.

PMID:
10823308
4.

Persistent hiccups associated with switching from paliperidone to amisulpride.

Cheng CM, Tsai SJ.

Psychiatry Clin Neurosci. 2015 Jun;69(6):383. doi: 10.1111/pcn.12239. Epub 2014 Oct 17. No abstract available.

5.

A pilot study of the safety and efficacy of amisulpride and risperidone in elderly psychotic patients.

Riedel M, Eich FX, Möller HJ.

Eur Psychiatry. 2009 Apr;24(3):149-53. doi: 10.1016/j.eurpsy.2008.10.005. Epub 2008 Dec 13.

PMID:
19070995
6.

Augmentation with amisulpride for schizophrenic patients non-responsive to risperidone monotherapy.

Toledo-Romero F, Molina JD, López-Rodríguez E, Amorin-Díaz M, Muñoz Algar MJ, Aparicio-Castro E.

Pharmacopsychiatry. 2015 Mar;48(2):51-7. doi: 10.1055/s-0034-1395524. Epub 2014 Nov 17.

PMID:
25402816
7.

Atypical antipsychotics and pituitary neoplasms in the WHO database.

Doraiswamy PM, Schott G, Star K, Edwards R, Mueller-Oerlinghausen B.

Psychopharmacol Bull. 2007;40(1):74-6. Erratum in: Psychopharmacol Bull. 2007;40(2):5.

PMID:
17285098
8.

Amisulpride vs. risperidone in the treatment of acute exacerbations of schizophrenia. Amisulpride study group.

Peuskens J, Bech P, Möller HJ, Bale R, Fleurot O, Rein W.

Psychiatry Res. 1999 Nov 8;88(2):107-17.

PMID:
10622347
9.

Amisulpride improves depressive symptoms in acute exacerbations of schizophrenia: comparison with haloperidol and risperidone.

Peuskens J, Möller HJ, Puech A.

Eur Neuropsychopharmacol. 2002 Aug;12(4):305-10.

PMID:
12126869
10.

Amisulpride: a review of its efficacy in schizophrenia.

Möller HJ.

Acta Psychiatr Scand Suppl. 2000;400:17-22. Review.

PMID:
10823307
11.

Augmentation with amisulpride for schizophrenic patients nonresponsive to antipsychotic monotherapy.

Lerner V, Bergman J, Borokhov A, Loewenthal U, Miodownik C.

Clin Neuropharmacol. 2005 Mar-Apr;28(2):66-71.

PMID:
15795548
12.

Serotonin reuptake inhibitor provoked recurrence of alcohol hallucinosis--remission with additive amisulpride medication. A case report.

Hermann D, Heinz A, Croissant B, Mann K.

Pharmacopsychiatry. 2004 Mar;37(2):90-2. No abstract available.

PMID:
15048618
13.

Switching to amisulpride monotherapy for treatment-resistant schizophrenia.

Kontaxakis VP, Havaki-Kontaxaki BJ, Ferentinos PP, Paplos KG, Soldatos CR.

Eur Psychiatry. 2006 Apr;21(3):214-7. Epub 2006 Mar 13.

PMID:
16531015
14.

Amisulpride treatment of somatoform disorders: not just chronic fatigue.

Goswami K, Saddichha S, Chaturvedi SK.

Am J Ther. 2014 Mar-Apr;21(2):e48-9. doi: 10.1097/MJT.0b013e3182383c78.

PMID:
23011165
15.

Clozapine augmentation with amisulpride.

Porcelli S, Serretti A, Bianchini O.

J Psychiatry Neurosci. 2014 Nov;39(6):E38-9. No abstract available.

16.

Choline acetyltransferase expression in rat prefrontal cortex and hippocampus after acute and chronic exposure to amisulpride, haloperidol, and risperidone.

Huang GB, Zhao T, Li CR, Sui ZY, Kang NI, Han EH, Chung YC.

Neurosci Lett. 2012 Oct 24;528(2):131-6. doi: 10.1016/j.neulet.2012.09.024. Epub 2012 Sep 19.

PMID:
22999925
17.

Successful treatment of Tourette's disorder with amisulpride.

Fountoulakis KN, Iacovides A, St Kaprinis G.

Ann Pharmacother. 2004 May;38(5):901. Epub 2004 Mar 9. No abstract available.

PMID:
15010520
18.

Is second-generation antipsychotic-induced hyperprolactinemia due to biologically active prolactin or to biologically inactive macroprolactin? Results from a prospective study.

Tschoner A, Engl J, Rettenbacher MA, Kaser S, Ott HW, Fleischhacker WW, Patsch JR, Ebenbichler CF.

J Clin Psychiatry. 2009 Feb;70(2):293-4. No abstract available.

PMID:
19265646
19.

Augmentation of clozapine with amisulpride: a promising therapeutic approach to refractory schizophrenic symptoms.

Kämpf P, Agelink MW, Naber D.

Pharmacopsychiatry. 2005 Jan;38(1):39-40. No abstract available.

PMID:
15706467
20.

Supplemental Content

Support Center